Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Largecap Value Opp Alphadex First Trust | FTA | May 14, 2024 | 75.39 | +0.31 |
Largo | LGO | May 14, 2024 | 1.63 | +2.52 |
Larimar Therapeutics | LRMR | May 14, 2024 | 7.88 | +7.65 |
Las Vegas Sands | LVS | May 14, 2024 | 46.32 | -1.28 |
Laser Photonics | LASE | May 14, 2024 | 2.24 | -14.50 |
Latham Group | SWIM | May 14, 2024 | 3.82 | +1.06 |
Latin America Alphadex First Trust | FLN | May 14, 2024 | 20.07 | +0.68 |
Lattice Semiconductor | LSCC | May 14, 2024 | 71.46 | +0.95 |
Laureate Education | LAUR | May 14, 2024 | 16.11 | -0.19 |
LAVA Therapeutics | LVTX | May 14, 2024 | 2.89 | -5.56 |
Lavoro | LVRO | May 14, 2024 | 5.85 | +2.81 |
Lazard A | LAZ | May 14, 2024 | 39.51 | +1.91 |
Lazard Global Total Return and Income Fund | LGI | May 14, 2024 | 16.22 | +1.00 |
Lazydays | GORV | May 14, 2024 | 3.83 | +3.23 |
LCI Industries | LCII | May 14, 2024 | 114.48 | -0.93 |
LCNB | LCNB | May 14, 2024 | 14.89 | +1.22 |
Lead Real Estate ADR | LRE | May 14, 2024 | 3.50 | +3.95 |
Leafly | LFLY | May 14, 2024 | 1.81 | -2.69 |
Leap Therapeutics | LPTX | May 14, 2024 | 2.75 | -2.83 |
Lear | LEA | May 14, 2024 | 132.08 | +0.28 |
Learn CW Investment SPAC | LCW | May 14, 2024 | 10.97 | +0.05 |
LeddarTech | LDTC | May 14, 2024 | 2.59 | +16.94 |
Lee Enterprises | LEE | May 14, 2024 | 11.73 | +0.77 |
Legacy Housing | LEGH | May 14, 2024 | 23.90 | +3.78 |
LegalZoom.com | LZ | May 14, 2024 | 9.60 | -1.54 |
Legato Merger III | LEGT | May 14, 2024 | 10.11 | 0.00 |
Legend Biotech ADR | LEGN | May 14, 2024 | 44.38 | +3.28 |
Legg Mason Low Volatility High Dividend ETF | LVHD | May 14, 2024 | 36.73 | -0.03 |
Leggett & Platt | LEG | May 14, 2024 | 12.33 | -1.28 |
Leidos | LDOS | May 14, 2024 | 146.60 | +0.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.